Alemtuzumab induction combined with reduced maintenance immunosuppression is associated with improved outcomes after lung transplantation: A single centre experience.

Alemtuzumab induction combined with reduced maintenance immunosuppression is associated with improved outcomes after lung transplantation: A single centre experience.

<h4>Question addressed by the study</h4>The value of induction therapy in lung transplantation is controversial. According to the ISHLT, only about 50% of patients transplanted within the last 10 years received induction therapy. We reviewed our institutional experience to investigate th...

Full description

Bibliographic Details
Main Authors: Alberto Benazzo, Stefan Schwarz, Moritz Muckenhuber, Thomas Schweiger, Gabriela Muraközy, Bernhard Moser, José Matilla Sigüenza, György Lang, Shahrokh Taghavi, Walter Klepetko, Konrad Hoetzenecker, Peter Jaksch, Cristopher Lambers
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0210443

Internet

https://doi.org/10.1371/journal.pone.0210443

Similar Items